Maximise salesforce effectiveness through telemarketing support
Duane Lacey, Managing Director, The Healthcare Partnership, on how telemarketing support boosts your sales team’s performance by enabling improved access to HCPs.
How does your telemarketing support enhance sales performance?
There is a recognised...
HFMA’s Chris Calkin on how the money in the NHS system works
How does the money flow through the NHS? Here’s the inside intelligence.
The complicated structure of the NHS is often impenetrable, even to those who...
Performance Associates’ Simon Toy on coaching, leadership & emotional intelligence
Since 2001 Performance Associates (PA) has been working across a range of industries including pharmaceutical sales, healthcare, manufacturing, IT, finance, insurance and FMCG, helping...
Martin Anderson, owner of Carrot Recruitment, on how to negotiate your way through a...
Today’s pharmaceutical and healthcare field teams are operating within increasingly challenging business environments, as companies relentlessly pursue new ways to optimise the commercialisation of...
CHASE Graduate Academy: Diving into the graduate talent pool
Words by Graham Hawthorn, Managing Director and Kate O’Neill, Graduate Recruitment Lead
With over 2 million students studying at more than 130 UK Universities, the...
Is being easily influenced really that bad? Asks Ryan Wooller, Head of Business Development...
Ryan Wooller, Head of Business Development at Star, discusses leadership and the importance of influence.
Recently, I was talking with a client around the challenges...
Emotional intelligence & the psychology of sales
Don’t keep battering away trying to increase sales, let In-Call Selling with Emotional Intelligence unlock your sales potential.
Many of you will have seen the...
Martin Anderson, Owner of Carrot Recruitment, explores the role of flexible resourcing in pharma.
Unlocking Hidden Talent
It’s a fact that many people in the pharmaceutical and healthcare industries still view the recruitment of permanent staff as the only...
Jo Spink: Changing behaviour in pharma
Behaviour change is a concept that takes place in our everyday lives, but only recently have we begun to understand the power of it...
AI in Pharmacovigilance – Re-imagining the ICSR processing
Over the last few decades, we have seen a spurt of medicines approved by regulatory authorities which have necessitated an increase in the need...
Latest articles
Mind the Generation Gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents anifrolumab results from Phase III TULIP trial
Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Popular articles
NHS Commercial Framework for Medicines consultation published
NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Mapping NHS change is key to customer engagement
Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Pf Power List 2019: Who is shaping the pharma & healthcare sector?
The Pf Power List has looked at who is making a difference in pharma and healthcare in 2019. This year has brought a range of developments...
Medopad and Janssen collaborate on novel digital biomarker for Alzheimer’s disease
Medopad has announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...